Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 03:33
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Tamboliin's 85.7% gross margin accelerated to, up from 14.32%.
The company's .32% marginal operating leverage also accelerated. Revenue growth slowed to .3%, down from .8%. On a daily basis, Tamboliin's .5 INR close price declined by .022 from 361.9 INR. Trading volume increased to 58,633 shares, up from 15,170 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 85.7 % | 14.32 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 14.32 % | 12.93 | ▲ |
| REVENUE_GROWTH_YOY | 10.3 % | 64.8 | ▼ |
| PRICE_CHANGE_PERCENT | -3.15 % | — | - |
| DAILY_VOLUME | 58,633 shares | 15,170 | ▲ |
| CLOSE_PRICE | 350.5 INR | 361.9 | ▼ |
Cite this
Source: Samhati evidence synthesis for TAMBOLIIN (2026-10-21). Observation: Tamboliin's 85.7% gross margin accelerated to, up from 14.32%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/tamboliin
Filing step-changes